Literature DB >> 20065338

Smoking cessation: the potential role of risk assessment tools as motivational triggers.

Robert P Young1, Raewyn J Hopkins, Melinda Smith, D Kyle Hogarth.   

Abstract

Smoking is the most important and preventable cause of morbidity and premature mortality in developed and developing countries. To date, efforts to reduce the burden of smoking have focused on non-personalised strategies. Anxiety about ill health, especially lung cancer and emphysema, is the foremost concern for smokers and a major reason for quitting. Recent efforts in cessation management focus on behaviour change and pharmacotherapy. The '3 Ts' (tension, trigger, treatment) model of behaviour change proposes that at any one time a smoker experiences varying degrees of motivational tension, which in the presence of a trigger may initiate or enhance quitting. Smokers' optimistic bias (ie, denial of one's own vulnerability) sustains continued smoking, while increasing motivational tension (eg, illness) favours quitting. The 1 year quit rates achieved when smokers encounter a life threatening event, such as a heart attack or lung cancer, are as much as 50-60%. Utilising tests of lung function and/or genetic susceptibility personalises the risk and have been reported to achieve 1 year quit rates of 25%. This is comparable to quit rates achieved among healthy motivated smokers using smoking cessation drug therapy. In this paper we review existing evidence and propose that identifying those smokers at increased risk of an adverse smoking related disease may be a useful motivational tool, and enhance existing public health strategies directed at smoking cessation.

Entities:  

Mesh:

Year:  2010        PMID: 20065338     DOI: 10.1136/pgmj.2009.084947

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  15 in total

1.  Teachable moments for health behavior change and intermediate patient outcomes.

Authors:  Susan A Flocke; Elizabeth Clark; Elizabeth Antognoli; Mary Jane Mason; Peter J Lawson; Samantha Smith; Deborah J Cohen
Journal:  Patient Educ Couns       Date:  2014-05-01

Review 2.  Smoking cessation strategies in Crohn's disease.

Authors:  Andrew Wilson
Journal:  Frontline Gastroenterol       Date:  2010-12-22

3.  Motivating smokers in the hospital pulmonary function laboratory to quit smoking by use of the lung age concept.

Authors:  David A Kaminsky; Theodore Marcy; Anne Dorwaldt; Richard Pinckney; Michael DeSarno; Laura Solomon; John R Hughes
Journal:  Nicotine Tob Res       Date:  2011-05-06       Impact factor: 4.244

4.  Interest in genetic testing for modest changes in breast cancer risk: implications for SNP testing.

Authors:  K D Graves; B N Peshkin; G Luta; W Tuong; M D Schwartz
Journal:  Public Health Genomics       Date:  2011-04-02       Impact factor: 2.000

5.  Biomedical risk assessment as an aid for smoking cessation.

Authors:  Carole Clair; Yolanda Mueller; Jonathan Livingstone-Banks; Bernard Burnand; Jean-Yves Camain; Jacques Cornuz; Myriam Rège-Walther; Kevin Selby; Raphaël Bize
Journal:  Cochrane Database Syst Rev       Date:  2019-03-26

Review 6.  Electronic cigarettes: a review of safety and clinical issues.

Authors:  Michael Weaver; Alison Breland; Tory Spindle; Thomas Eissenberg
Journal:  J Addict Med       Date:  2014 Jul-Aug       Impact factor: 3.702

7.  Patient compliance based on genetic medicine: a literature review.

Authors:  Kai Insa Schneider; Jörg Schmidtke
Journal:  J Community Genet       Date:  2013-08-10

8.  Utility of incorporating a gene-based lung cancer risk test on uptake and adherence in a community-based lung cancer screening pilot study.

Authors:  V K Lam; R J Scott; P Billings; E Cabebe; R P Young
Journal:  Prev Med Rep       Date:  2021-05-16

9.  Clinical applications of gene-based risk prediction for lung cancer and the central role of chronic obstructive pulmonary disease.

Authors:  R P Young; R J Hopkins; G D Gamble
Journal:  Front Genet       Date:  2012-10-16       Impact factor: 4.599

10.  Genetic evidence linking lung cancer and COPD: a new perspective.

Authors:  Robert P Young; Raewyn J Hopkins; Gregory D Gamble; Carol Etzel; Randa El-Zein; James D Crapo
Journal:  Appl Clin Genet       Date:  2011-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.